Investıgatıon of Temporomandıbular Dysfunctıon in Patıents Wıth Breast Cancer-Related Lymphedema
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Breast Cancer
- Sponsor
- arife akbulut
- Enrollment
- 38
- Locations
- 1
- Primary Endpoint
- temporomandibular dysfunction
- Status
- Completed
- Last Updated
- last year
Overview
Brief Summary
This study is the first study to examine temporomandibular joint dysfunction (TMD) in patients with breast cancer. The aim of the study was to investigate the relationship between lymphedema (LÖ) and TMD in patients with breast cancer. Socio-demographic characteristics of 38 individuals included in the study were recorded. Patients were divided into stage 0, 1 and 2 groups according to their LÖ stage and mild, moderate and advanced groups according to their TMD levels. In the evaluation of severity of lymphedema, Symptoms and Signs of TMD, pain threshold and tolerance assessment and normal range of motion, anxiety and depression, posture analysis environmental measurement, Craniomandibular Dysfunction Index for Clinical, Visual Analogue Scale (VAS) and algometer , goniometer and inclinometer, Turkish version of the Hospital Anxiety and Depression Scale (HAD) ,photogrammetric assessment method and inclinometer were used
Investigators
arife akbulut
LECTURER
Ankara Yildirim Beyazıt University
Eligibility Criteria
Inclusion Criteria
- •Female patients aged 18-75 years who were treated for unilateral breast cancer and developed breast cancer-related LE were included in the study
Exclusion Criteria
- •Patients with general joint diseases affecting the head and neck region that may cause TMD (e.g. rheumatoid arthritis),
- •jaw fracture,
- •trauma or orthognathic surgery history,
- •cervical disc herniation,
- •congenital disease,
- •facial paralysis,
- •patients who have been treated for TMD for the last 3 months and patients who use antidepressant drugs were excluded.
Outcomes
Primary Outcomes
temporomandibular dysfunction
Time Frame: through study completion, an average of 1 year
The Clinical Craniomandibular Dysfunction Index (CDI) was used. CDI consists of five components including limited mandibular normal joint motion (RMJ), pain during mandibular RMJ, pain during TMJ palpation, pain during palpation of masticatory muscles and pain during mandibular function. 3 points can be given for each component as 0, 1 or 5 points and individuals are graded as no TMD (0 points), mild TMD (1-4 points), moderate TMD (5-9 points) and severe TMD (10-25 points) according to the scores received.
lymhedema
Time Frame: through study completion, an average of 1 year
It was determined according to the criteria determined by the International Lymphology Association . To determine the severity of LE, circumference measurements were taken from both arms at 4 cm intervals. If the difference between the two extremities was up to 1.5 cm, it was classified as "normal", between 1.5-3 cm as "mild", between 3-5 cm as "moderate" and over 5 cm as "severe" LE
Secondary Outcomes
- pain(through study completion, an average of 1 year)
- posture(through study completion, an average of 1 year)
- Measurement of range of motion of cervical joints and shoulder joint(through study completion, an average of 1 year)
- anxiety-depression(through study completion, an average of 1 year)